GRAIL (NASDAQ:GRAL) Stock Price Down 6.2% - Time to Sell?

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) traded down 6.2% during mid-day trading on Friday . The company traded as low as $45.60 and last traded at $45.44. 721,583 shares were traded during trading, a decline of 43% from the average session volume of 1,262,627 shares. The stock had previously closed at $48.44.

Analysts Set New Price Targets

Several analysts have commented on the stock. Canaccord Genuity Group raised their target price on shares of GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Morgan Stanley increased their price objective on shares of GRAIL from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

GRAIL Stock Down 5.6%

The company has a market capitalization of $1.55 billion and a P/E ratio of -0.71. The business has a fifty day moving average price of $37.25 and a 200 day moving average price of $31.08.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, beating the consensus estimate of ($4.03) by $0.93. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. The firm had revenue of $31.84 million for the quarter, compared to analysts' expectations of $35.80 million. As a group, equities analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Insider Transactions at GRAIL

In related news, CFO Aaron Freidin sold 41,150 shares of GRAIL stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,396,219.50. Following the sale, the chief financial officer now owns 294,020 shares of the company's stock, valued at approximately $9,976,098.60. The trade was a 12.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 48,213 shares of the company's stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,635,867.09. Following the sale, the president now owns 511,460 shares in the company, valued at $17,353,837.80. The trade was a 8.61% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 183,398 shares of company stock valued at $6,222,694 over the last 90 days.

Institutional Investors Weigh In On GRAIL

Several large investors have recently made changes to their positions in GRAL. S.A. Mason LLC increased its holdings in GRAIL by 50.1% during the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after buying an additional 500 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of GRAIL by 28.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock valued at $76,000 after acquiring an additional 623 shares during the period. HighTower Advisors LLC increased its stake in shares of GRAIL by 5.7% during the 1st quarter. HighTower Advisors LLC now owns 11,591 shares of the company's stock worth $296,000 after purchasing an additional 627 shares during the last quarter. KBC Group NV raised its holdings in shares of GRAIL by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after purchasing an additional 933 shares during the period. Finally, Caldwell Sutter Capital Inc. acquired a new stake in GRAIL in the 1st quarter valued at about $28,000.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.